Author

Lijuan Huang

Tokyo University of ScienceORCID 0000-0003-2727-9454Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Etsuko Miyamoto‐SatoiD· 1 shared Masamichi Ishizaka· 1 shared Satoshi Imanishi· 1 shared Shoko ItakuraiD· 1 shared Tomohiro YamaguchiiD· 1 shared Yoichi Iwasaki· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Etsuko Miyamoto‐SatoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologybioRxivPreprintApr 23, 2021

In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor

Satoshi Imanishi, Lijuan Huang, Shoko Itakura…·Etsuko Miyamoto‐Sato

This paper develops a chemical knockdown strategy called CANDDY to degrade KRAS G12D/V mutants in vivo, showing tumor suppression through proteasomal degradation independent of ubiquitination.

4 citations

humanproteomics

𝕏 PostBluesky